Document Detail


How to manage antithrombotic treatment during percutaneous coronary interventions in patients receiving long-term oral anticoagulation: to "bridge" or not to "bridge"?
MedLine Citation:
PMID:  20884441     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIMS: The management of patients on long-term oral anticoagulation and referred for percutaneous coronary interventions represents a substantial challenge to the physician who must balance the risks of periprocedural haemorrhage, thrombotic complications and thromboembolism.
METHODS AND RESULTS: Currently, a standard recommendation for these patients has been the discontinuation of warfarin before invasive cardiac procedures, since uninterrupted anticoagulation is assumed to increase bleeding and access site complications. Unfractionated or low molecular weight heparins are administered as a "bridging therapy" in patients at moderate to high risk of thromboembolism. The present review summarises the available data on the safety of performing coronary interventions during uninterrupted oral anticoagulation therapy and shows that bridging therapy offers no advantage over this simple strategy and prolongs hospitalisation and may delay interventions in acute coronary syndromes. Sub-therapeutic anticoagulation during crossover phases may also increase the potential for thromboembolism.
CONCLUSIONS: Bridging therapy offers no advantage over the simple strategy of performing cardiac interventions during uninterrupted therapeutic oral anticoagulation therapy.
Authors:
K E Juhani Airaksinen; Axel Schlitt; Andrea Rubboli; Pasi Karjalainen; Gregory Y H Lip
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  6     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-10-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  520-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Turku University Hospital, Finland. juhani.airaksinen@tyks.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vascular response to a third generation everolimus-eluting stent.
Next Document:  Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a sys...